The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-475

I think the share price action is to be expected with the great gains we have made in the last month, as most of us have seen these spikes prior to announcements before, then some sell the news as the climax is over till the next announcement. We have Phase 2 trials now, maybe incorporating Phase 3.

This takes time, there is another biotech i follow expecting Phase 3 approval in the meantime, i expect this to increase more due to phase 3 being final approval, but come approval i dont see the jump as much as in the next 4 months, mirroring PAA's awesome climb. Stay confident, this will climb, maybe not as dramatically for the next year but it is expected to climb, then watch for Phase 2 readout timeframes!!